(1) Bolanowski M, Ruchała M, Zgliczyński W, et al. Diagnostics and treatment of acromegaly – updated recommendations of the Polish Society of Endocrinology. Endokrynol Pol 2019; 70(1):2-18. DOI:10.5603/EP.a2018.0093.
Google Scholar
(2) Grynberg M, Salenave S, Young J, et al.: Female gonadal function before and after treatment of acromegaly. Journal of Clinical Endocrinology and Metabolism 2010; 95:4518-4525. DOI:10.1210/jc.2009-2815.
Google Scholar
(3) Caron P, Broussaud S, Bertherat J, et al.: Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. Journal of Clinical Endocrinology and Metabolism 2010; 95:4680-4687. DOI:10.1210/jc.2009-2331.
Google Scholar
(4) Cheng V, Faiman C, Kennedy L, et al.: Pregnancy and acromegaly: a review. Pituitary 2012; 15:59-63. DOI:10.1007/s11102-011-0330-3.
Google Scholar
(5) Jallad RS, Shimon I, Fraenkel M, et al.: Outcome of pregnancies in a large cohort of women with acromegaly. Clinical Endocrinology 2018; 88:896-907. DOI:10.1111/cen.13599.
Google Scholar
(6) Hannon A, O’Shea T, Thompson C, et al.: Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations. European Journal of Endocrinology 2019; 180(4):21-29. DOI:10.1530/EJE-18-0688.
Google Scholar
(7) Abucham J, Bronstein MD, Dias ML. Management of Endocrine Disease: Acromegaly and pregnancy: a contemporary review. European Journal of Endocrinology 2017; 177(1):1-12. DOI:10.1530/EJE-16-1059.
Google Scholar
(8) Assal A, Malcolm J, Lochnan H, et al.: Preconception counselling for women with acromegaly: More questions than answers. Obstet Med 2016; 9(1):9-14. DOI:10.1177/1753495X15598699.
Google Scholar
(9) Dias M, Boguszewski C, Gadelha M, et al.: Acromegaly and pregnancy: a prospective study. European Journal of Endocrinology 2014; 170:303-312. DOI:10.1530/EJE-13-0460.
Google Scholar
(10) Cheng S, Grasso L, Martinez-Orozco JA, et al.: Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature. Clinical Endocrinology 2012; 76(2):264-271. DOI:10.1111/j.1365-2265.2011.04180.x
Google Scholar
(11) Persechini ML, Gennero I, Grunenwald S, et al. Decreased IGF-1 concentration during the first trimester of pregnancy in women with normal somatotroph function. Pituitary 2015 Aug; 18(4):461-4. DOI:10.1007/s11102-014-0596-3.
Google Scholar
(12) Muhammad A, Neggers SJ, van der Lely AJ. Pregnancy and acromegaly. Pituitary 2017 Feb; 20(1):179-184. DOI:10.1007/s11102-016-0740-3.
Google Scholar
(13) Yen SS. Endocrine – metabolic adaptations in pregnancy. In: Reproductive Endocrinology: Physiology Pathophysiology and Clinical Management. Eds Yen SSC, Jaffe RB & Barbieri RL. Philadelphia: WB Saunders Company 1991.
Google Scholar
(14) Yang MJ, Tseng JY, Chen CY, et al.: Changes in maternal serum insulin-like growth factor-I during pregnancy and its relationship to maternal anthropometry. Journal of the Chinese Medical Association 2013; 76: 635-639. DOI:10.1016/j.jcma.2013.07.004.
Google Scholar
(15) Katznelson L, Laws ER, Melmed S, et al.: Acromegaly: an Endocrine Society Clinical Practice guideline. Journal of Clinical Endocrinology and Metabolism 2014; 99:3933-3951. DOI:10.1210/jc.2014-2700.
Google Scholar
(16) Gonzalez JG, Elizondo G, Saldivar D, et al.: Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. American Journal of Medicine 1988; 85(2):217-220. DOI:10.1016/S0002-9343(88)80346-2.
Google Scholar
(17) Dinç H, Esen F, Demirci A, et al. Pituitary dimensions and volume measurements in pregnancy and post partum. MR assessment. Acta Radiol 1998 Jan; 39(1):64-9.
Google Scholar
(18) Kupersmith MJ, Rosenberg C, Kleinberg D. Visual loss in pregnant women with pituitary adenomas. Annals of internal medicine 1994; 12:1473-477. DOI:10.7326/0003-4819-121-7 -199410010-00001.
Google Scholar
(19) Kasuki L, Neto LV, Takiya CM, et al. Growth of an aggressive tumor during pregnancy in an acromegalic patient. Endocr J 2012; 59(4):313-9. Epub 2012 Jan 12.
Google Scholar
(20) Hannon AM, Frizelle I, Kaar G, et al. Octreotide use for rescue of vision in a pregnant patient with acromegaly. Endocrinol Diabetes Metab Case Rep. 2019 May 20; 2019. DOI:10.1530/EDM-19-0019.
Google Scholar
(21) Chanson P, Vialon M, Caron P. An update on clinical care for pregnant women with acromegaly. Expert Rev Endocrinol Metab 2019 Mar; 14(2):85-96. DOI:10.1080/17446651.2019.1571909. Epub 2019 Jan 30.
Google Scholar
(22) Haliloglu O, Dogangun B, Ozcabi B, et al.: General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers. Pituitary 2016; 19:391-398. DOI:10.1007/s11102-016-0717-2.
Google Scholar
(23) Kintiraki E, Papakatsika S, Kotronis G, et al.: Pregnancy-induced hypertension. Hormones 2015; 14:211-223. DOI:10.14310/horm.2002.1582.
Google Scholar
(24) Mozas J, Ocon E, Lopez de la Torre M, et al.: Successful pregnancy in a woman with acromegaly treated with somatostatin analog (octreotide) prior to surgical resection. International Journal of Gynaecology and Obstetrics 1999; 65:71-73. DOI:10.1016/S0020-7292(98)00221-5.
Google Scholar
(25) de Menis E, Billeci D, Marton E, et al.: Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: a case report. Journal of Clinical Endocrinology and Metabolism 1999; 84:1489. DOI:10.1210/jcem.84.4.5625-5.
Google Scholar
(26) Takano T, Saito J, Soyama A, et al.: Normal delivery following an uneventful pregnancy in a Japanese acromegalic patient after discontinuation of octreotide long acting release formulation at an early phase of pregnancy. Endocrine Journal 2006; 53:209-212. DOI:10.1507/endocrj.53.209.
Google Scholar
(27) Maffei P, Tamagno G, Nardelli GB, et al.: Effects of octreotide exposure during pregnancy in acromegaly. Clinical Endocrinology 2010; 72:668-677. DOI:10.1111/j.1365-2265. 2009.03706.x.
Google Scholar
(28) Ricci E, Parazzini F, Motta T, et al.: Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reproductive Toxicology 2002; 16:791-793. DOI:10.1016/S0890-6238(02)00055-2.
Google Scholar
(29) Colao A, Abs R, Barcena DG, et al.: Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study. Clinical Endocrinology 2008; 68:66-71. DOI:10.1111/j.1365-2265.2007.03000.x.
Google Scholar
(30) Molitch ME. Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma. European Journal of Endocrinology 2015; 172:205-213. DOI:10.1530/EJE-14-0848.
Google Scholar
(31) van der Lely AJ, Gomez R, Heissler JF, et al. Pregnancy in acromegaly patients treated with pegvisomant. Endocrine 2015; 49:769-773. DOI:10.1007/s12020-014-0508-3.
Google Scholar